1. The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth. Warolin J, Coenen KR, Kantor JL, Whitaker LE, Wang L, Acra SA, Roberts LJ, Buchowski MS (2014) Pediatr Obes 9(1): 43-52
    › Primary publication · 23296459 (PubMed) · PMC3775931 (PubMed Central)
  2. The yeast eukaryotic translation initiation factor 2B translation initiation complex interacts with the fatty acid synthesis enzyme YBR159W and endoplasmic reticulum membranes. Browne CM, Samir P, Fites JS, Villarreal SA, Link AJ (2013) Mol Cell Biol 33(5): 1041-56
    › Primary publication · 23263984 (PubMed) · PMC3623073 (PubMed Central)
  3. The best-laid plans. Harris RC (2013) Am J Physiol Renal Physiol 304(8): F1086-7
    › Primary publication · 23269642 (PubMed) · PMC3625842 (PubMed Central)
  4. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets. Duvernay M, Young S, Gailani D, Schoenecker J, Hamm HE, Hamm H (2013) Mol Pharmacol 83(4): 781-92
    › Primary publication · 23307185 (PubMed) · PMC3608438 (PubMed Central)
  5. Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs. Coate KC, Kraft G, Irimia JM, Smith MS, Farmer B, Neal DW, Roach PJ, Shiota M, Cherrington AD (2013) Diabetes 62(2): 392-400
    › Primary publication · 23028137 (PubMed) · PMC3554368 (PubMed Central)
  6. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms. Schwetz TA, Ustione A, Piston DW (2013) Am J Physiol Endocrinol Metab 304(2): E211-21
    › Primary publication · 23211512 (PubMed) · PMC3543566 (PubMed Central)
  7. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Leamy AK, Egnatchik RA, Young JD (2013) Prog Lipid Res 52(1): 165-74
    › Primary publication · 23178552 (PubMed) · PMC3868987 (PubMed Central)
  8. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Milne GL, Gao B, Terry ES, Zackert WE, Sanchez SC (2013) Free Radic Biol Med : 36-44
    › Primary publication · 23044261 (PubMed) · PMC4306329 (PubMed Central)
  9. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor. Longuet C, Robledo AM, Dean ED, Dai C, Ali S, McGuinness I, de Chavez V, Vuguin PM, Charron MJ, Powers AC, Drucker DJ (2013) Diabetes 62(4): 1196-205
    › Primary publication · 23160527 (PubMed) · PMC3609565 (PubMed Central)
  10. Liver glycogen loading dampens glycogen synthesis seen in response to either hyperinsulinemia or intraportal glucose infusion. Winnick JJ, An Z, Kraft G, Ramnanan CJ, Irimia JM, Smith M, Lautz M, Roach PJ, Cherrington AD (2013) Diabetes 62(1): 96-101
    › Primary publication · 22923473 (PubMed) · PMC3526057 (PubMed Central)